Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
Breast Cancer Research and Treatment|April 13, 2013
A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancerShanu Modi, Cristina Saura, Charles Henderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancerShanu Modi, Katherine S Panageas, Elaine T Duck, et al.
Cancer Research|May 19, 2006
HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanismKotha Subbaramaiah, Louise R Howe, Elisa R Port, et al.
Breast Cancer Research and Treatment|October 8, 2017
Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impactDavid B Page, Hannah Wen, Edi Brogi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-upLee K Tan, Dilip Giri, Amanda J Hummer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2012
Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancerSarat Chandarlapaty, Rita A Sakr, Dilip Giri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907Alice B Kornblith, Lan Lan, Laura Archer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 22, 2015
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal CarcinomaMolly P Hogan, Debra A Goldman, Brittany Dashevsky, et al.
Pageof 13